Proprietary technology.

Strong market presence.

Proven business model.

Powerful growth potential.

Take a good look at Possis and see our strength.

Look deeper, and you’ll see something else: our strong, unwavering commitment to fight the devastating effects of intra-vascular blood clots. More than 10 million people suffer from these circulation-blocking blood clots every year. So far, our pioneering, market-leading AngioJet® technology has helped to save more than 250,000 lives and limbs.

We’re just getting started.